Surmodics, Inc. announced the full commercial release of the Pounce XL thrombectomy system. Pounce XL is intended for the ...

Surmodics has initiated a full commercial release of its Pounce XL thrombectomy system for acute or chronic clot removal.

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care ...

All had severe calcification of iliac arteries. Eight patients required a bypass from the thoracic aorta and two from the infrarenal level. Revascularization was successful in 10 patients.